(2-((5-Chloro-2-((2,5-dichloro-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide

ID: ALA5081174

Chembl Id: CHEMBL5081174

PubChem CID: 166627448

Max Phase: Preclinical

Molecular Formula: C28H35Cl3N7OP

Molecular Weight: 622.97

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CN1CCN(C2CCN(c3cc(Cl)c(Nc4ncc(Cl)c(Nc5ccccc5P(C)(C)=O)n4)cc3Cl)CC2)CC1

Standard InChI:  InChI=1S/C28H35Cl3N7OP/c1-36-12-14-37(15-13-36)19-8-10-38(11-9-19)25-17-20(29)24(16-21(25)30)34-28-32-18-22(31)27(35-28)33-23-6-4-5-7-26(23)40(2,3)39/h4-7,16-19H,8-15H2,1-3H3,(H2,32,33,34,35)

Standard InChI Key:  NGCUFPTULYPMMY-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA5081174

    ---

Associated Targets(Human)

EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PC-9 (1037 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1299 (3248 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Egfr Epidermal growth factor receptor erbB1 (106 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 622.97Molecular Weight (Monoisotopic): 621.1706AlogP: 6.39#Rotatable Bonds: 7
Polar Surface Area: 76.63Molecular Species: NEUTRALHBA: 8HBD: 2
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski): 2
CX Acidic pKa: 12.58CX Basic pKa: 8.35CX LogP: 4.95CX LogD: 3.88
Aromatic Rings: 3Heavy Atoms: 40QED Weighted: 0.29Np Likeness Score: -1.28

References

1. Li S, Zhang T, Zhu SJ, Lei C, Lai M, Peng L, Tong L, Pang Z, Lu X, Ding J, Ren X, Yun CH, Xie H, Ding K..  (2022)  Optimization of Brigatinib as New Wild-Type Sparing Inhibitors of EGFRT790M/C797S Mutants.,  13  (2.0): [PMID:35178175] [10.1021/acsmedchemlett.1c00555]

Source